Register Cart 0

Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back Subscribe

Opinion: [Withdrawal of Rimonabant – Walking the Tightrope of 21st Century Pharmaceutical Regulation?]

Author(s): David Taylor

Volume 4, Issue 1, 2009

Page: [2 - 4] Pages: 3

DOI: 10.2174/157488609787354396

Price: $65

Abstract

Full text available

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

26

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Disulfide Stress and its Targets in Acute Pancreatitis
Inflammation & Allergy - Drug Targets (Discontinued)

Target Enzyme in Alzheimer’s Disease: Acetylcholinesterase Inhibitors
Current Topics in Medicinal Chemistry

Facts and Fiction: Cellular Models for High Throughput Screening for HIV-1 Reactivating Drugs
Current HIV Research

Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)

Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach
Current Pharmaceutical Design

Meet Our Editorial Board Member
Current Pharmacogenomics and Personalized Medicine

Roles of Adrenomedullin in Hypertension and Hypertensive Organ Damage
Current Hypertension Reviews

Biological Importance of Phenol Derivatives as Potent Bioactive Compound: A Review
Letters in Organic Chemistry

Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design

Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands
Current Topics in Medicinal Chemistry

Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics
Medicinal Chemistry

Conflict of Interest as a Possible Factor in the Rise of Pediatric Bipolar Disorder
Adolescent Psychiatry

Inhibitors of Cysteine Proteases
Current Topics in Medicinal Chemistry

Intravenous Application of Allogenic Peripheral Blood-Derived Mesenchymal Stem Cells: A Safety Assessment in 291 Equine Recipients
Current Stem Cell Research & Therapy

Targeting ADAM12 in Human Disease: Head, Body or Tail?
Current Pharmaceutical Design

Disorder-Specific Emotional Imagery for Differential and Quantitative Assessment of Agoraphobia
Current Pharmaceutical Design

The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders
Current Drug Targets - CNS & Neurological Disorders

Therapeutic Potential of Drug Delivery by Means of Lipid Nanoparticles: Reality or İllusion?
Current Pharmaceutical Design

Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design

Chlorophytum borivilianum: A White Gold for Biopharmaceuticals and Neutraceuticals
Current Pharmaceutical Biotechnology

© 2024 Bentham Science Publishers | Privacy Policy